Novo Nordisk A/S (NVO)
123.05
-0.97
(-0.78%)
USD |
NYSE |
May 03, 16:00
123.01
-0.04
(-0.03%)
Pre-Market: 20:00
Novo Nordisk Price: 123.05 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 122.92 | 123.77 | 121.29 | 123.05 | 5.711M |
| May 02, 2024 | 127.94 | 127.94 | 123.83 | 124.02 | 8.487M |
| May 01, 2024 | 127.80 | 130.13 | 127.50 | 129.21 | 5.218M |
| Apr 30, 2024 | 128.05 | 130.46 | 127.49 | 128.31 | 7.841M |
| Apr 29, 2024 | 127.32 | 127.97 | 126.52 | 126.88 | 2.111M |
| Apr 26, 2024 | 126.15 | 127.90 | 125.99 | 126.85 | 3.312M |
| Apr 25, 2024 | 123.69 | 125.85 | 123.21 | 125.79 | 3.434M |
| Apr 24, 2024 | 127.16 | 127.32 | 125.35 | 126.16 | 3.143M |
| Apr 23, 2024 | 126.57 | 128.76 | 126.34 | 128.64 | 3.704M |
| Apr 22, 2024 | 122.59 | 126.25 | 122.57 | 125.26 | 3.798M |
| Apr 19, 2024 | 123.48 | 124.54 | 122.46 | 122.71 | 5.183M |
| Apr 18, 2024 | 123.30 | 124.10 | 122.51 | 122.75 | 2.841M |
| Apr 17, 2024 | 124.95 | 125.21 | 123.26 | 124.53 | 3.075M |
| Apr 16, 2024 | 123.07 | 124.25 | 121.79 | 123.45 | 3.044M |
| Apr 15, 2024 | 125.81 | 126.05 | 123.52 | 123.90 | 2.897M |
| Apr 12, 2024 | 126.74 | 127.06 | 124.35 | 124.51 | 3.343M |
| Apr 11, 2024 | 125.48 | 125.88 | 124.13 | 125.40 | 2.419M |
| Apr 10, 2024 | 123.39 | 125.26 | 123.24 | 124.93 | 3.025M |
| Apr 09, 2024 | 126.18 | 126.74 | 124.22 | 124.86 | 3.215M |
| Apr 08, 2024 | 127.00 | 127.63 | 125.99 | 127.46 | 3.017M |
| Apr 05, 2024 | 124.67 | 126.17 | 124.60 | 125.86 | 4.998M |
| Apr 04, 2024 | 126.90 | 127.48 | 123.77 | 123.96 | 4.007M |
| Apr 03, 2024 | 125.38 | 128.13 | 125.38 | 126.99 | 3.616M |
| Apr 02, 2024 | 125.05 | 126.68 | 124.08 | 126.46 | 4.322M |
| Apr 01, 2024 | 129.11 | 129.11 | 127.15 | 127.55 | 3.065M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
23.40
Minimum
May 16 2019
135.92
Maximum
Mar 07 2024
54.89
Average
50.62
Median
Sep 19 2022
Price Benchmarks
| Amgen Inc | 311.29 |
| Vertex Pharmaceuticals Inc | 401.08 |
| Viking Therapeutics Inc | 76.97 |
| Evaxion Biotech AS | 3.95 |
| Moderna Inc | 125.00 |
Price Related Metrics
| PE Ratio | 42.48 |
| PS Ratio | 15.53 |
| PEG Ratio | 0.8042 |
| Price to Book Value | 38.37 |
| Price to Free Cash Flow | 75.27 |
| Earnings Yield | 2.35% |
| Market Cap | 548.93B |
| PEGY Ratio | 0.7875 |
| Operating PE Ratio | 34.65 |
| Normalized PE Ratio | 42.48 |